'For quarter ending June 2024, consolidated Net sales (including other operating income) of Biocon has increased 0.30% to Rs 3432.9 crore compared to quarter ended June 2023. Inter-segment sales came down from Rs 100.60 crore to Rs 99.50 crore
Profit before interest, tax and other unallocable items (PBIT) has jumped 461.19% to Rs 1,151.00 crore.
Overall PBIT margin rose from 5.82% to 32.58%.
Operating profit margin has declined from 20.87% to 18.07%, leading to 13.16% decline in operating profit to Rs 620.40 crore. Raw material cost as a % of total sales (net of stock adjustments) decreased from 29.17% to 24.44%. Purchase of finished goods cost rose from 7.89% to 11.61%. Employee cost increased from 16.48% to 21.47%. Other expenses fell from 26.15% to 24.85%. Preoperation capitalised expenses rose from 0.14% to 0.91%.
Other income rose 1,113.37% to Rs 1134...
Pleaselogin & subscribe to view the full report.
More Reports
|
|